Results of an artificial-lung survey to lung transplant program directors

Journal of Heart and Lung Transplantation

Volumn 21, Issue 4, 2002, Pages 467-473

  Haft, Jonathan W ^a   Griffith, Bartley P ^b   Hirschl, Ronald B ^a   Bartlett, Robert H ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL LUNG; ARTIFICIAL ORGAN; CHRONIC LUNG DISEASE; DEVICE; HUMAN; LUNG TRANSPLANTATION; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

ANIMALS; ARTIFICIAL ORGANS; CLINICAL TRIALS, PHASE I; HEALTH CARE SURVEYS; HUMANS; LUNG; LUNG DISEASES; LUNG TRANSPLANTATION; PROGRAM EVALUATION; TREATMENT OUTCOME; UNITED STATES;

EID: 0036130197     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(01)00378-3     Document Type: Article

References (20)

1. Medical progress; lung transplantation
2. The donor lung; conservation of a precious resource
3. International guidelines for the selection of lung transplant candidates
4. Extracorporeal life support for 100 adult patients with severe respiratory failure
5. Extracorporeal life support for severe pediatric respiratory failure; an updated experience 1991-93
6. Medical progress; implantable left ventricular assist devices
7. Progress with the development of the intravenous membrane oxygenator
8. Development of an ultracompact integrated heart-lung assist device
9. Testing of an intrathoracic artificial lung in a pig model
10. Hemodynamic effect of a low-resistance artificial lung in series with the native lungs of sheep
11. Development of an implantable artificial lung; challenges and progress
12. Development of an ambulatory artificial lung in an ovine survival model
13. Improved right heart function with a compliant inflow artificial lung in series with the pulmonary circulation
14. An artificial lung reduces pulmonary input impedance and improves right ventricular efficiency in acute pulmonary hypertension
15. New UNOS rules; historical background and implications for transplant management
16. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
17. Lung transplant waiting list; differential outcome of type of end-stage lung disease, one year after registration
18. Donor criteria and evaluation
19. Liberalization of donor criteria may expand the donor pool without adverse consequences in lung transplantation
20. Successful outcome of lung transplantation is not compromised by the use of marginal donors